Knowledge Action Portal on NCDs

The Role of Health Technology Assessment in Medicine Pricing and Reimbursement

Health Action International (HAI)

27 Nov 2018

The Role of Health Technology Assessment in Medicine Pricing and Reimbursement

This policy brief summarises the key points from the review on the role of health technology assessment (HTA) in medicine pricing and reimbursement with a focus on its use in low- and middle-income countries (LMICs).

Access
Briefs & Fact Sheets Access to essential medicines and servicesDigital health and innovation

Related Resources

Union for International Cancer Control (UICC)

UICC, WCRFI and McCabe Centre for Law and Cancer's response to the Zero Draft of the 2025 Political Declaration on NCDs and Mental Health

Strategy document

03 Jun 2025

FDI World Dental Federation (FDI)

NO HEALTH WITHOUT ORAL HEALTH - Advocacy priorities for the 4th United Nations High–Level Meeting (UN HLM) on Noncommunicable diseases (NCDs) and mental health 2025

Guide

02 Jun 2025

PATH, Coalition for Access to NCD Medicines and Products

The case for financing action on noncommunicable diseases – even, and especially, in times of crisis

Briefs & Fact Sheets

28 May 2025

PATH, Coalition for Access to NCD Medicines

Reflections by the Coalition for Access to NCD Medicines and Products on the Zero Draft of the Political Declaration

Briefs & Fact Sheets

28 May 2025

World Heart Federation (WHF)

WHF Response to Zero Draft of the Political Declaration on NCDs and Mental Health 2025

Strategy document

27 May 2025

World Heart Federation (WHF)

WHF Statement on Reshaping and Strengthening Health Systems and All Forms of Financing to Meet the Needs of People Living with and at Risk of Noncommunicable Diseases and Mental Health Conditions

Declaration

27 May 2025
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Read More